Implantierbare Medizinische Vorrichtung zur Vorübergehenden Reduktion eines Schutzintervalls

EP4813443 30. September 2026

Anmelder: BIOTRONIK SE & Co. KG 🇩🇪

Details

Veröffentlichungs-Nr.
EP4813443
Anmeldetag
24. März 2025
Veröffentlichung
30. September 2026
Rechtsraum
EP
Offizieller Volltext

Abstract

The present invention relates to an implantable medical device (1) for stimulating a human or animal heart. During operation, the implantable medical device (1) executes a method comprising the following steps: a) detecting at least one right ventricular depolarization (RVs) with a first electrode (5) or delivering at least one right ventricular pacing pulse (RVp) with the first electrode (5); b) determining if a scheduled left ventricular pacing pulse (LVp) can be delivered with a second electrode (9), wherein a delivery of the left ventricular pacing pulse (LVp) is subject to an expiration of a presettable protective interval (LVURI) that is initiated by a preceding left ventricular pacing pulse (LVp) delivered with the second electrode (9), a preceding left ventricular depolarization (LVs) detected with the second electrode (9), or a preceding logic event (LVp(PH)) triggered instead of a preceding left ventricular pacing pulse (LVp) at the same time at which the preceding left ventricular pacing pulse (LVp) was scheduled to be delivered; and c) if the left ventricular pacing pulse (LVp) cannot be delivered since the presettable protective interval (LVURI) is not yet expired , reducing a following presettable protective interval (LVURI) such that it elapses before a respective subsequent left ventricular pacing pulse (LVp) is scheduled.

Anmelder

Firma
BIOTRONIK SE & Co. KG
Land
🇩🇪 Deutschland
🇩🇪 BIOTRONIK

Deutscher Medizintechnikhersteller, entwickelt Herzschrittmacher, Defibrillatoren und Gefäßimplantate wie Stents für die Behandlung von Herz-Kreislauf-Erkrankungen.

1.470 Patente in unserer Datenbank

Noch Fragen?

Wir helfen Ihnen gerne weiter. Schreiben Sie uns einfach.

Kontakt aufnehmen